Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Cancer AND Oncology). Showing records 1 – 30 of 2574 total matches.

[1] [2] [3] [4] [5] … [86]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Languages

Country

▼ Search Limiters


University of Minnesota

1. Zamora, Edward Anthony. Dual labeling of syngeneic tumor cells for in vivo and in vitro localization.

Degree: MS, Microbiology, immunology and cancer biology, 2012, University of Minnesota

University of Minnesota M.S. thesis. August 2012. Major: Microbiology, immunology and cancer biology. Advisor: Jaime Modiano, V.M.D, Ph.D. 1 computer file (PDF); v, 40 pages.… (more)

Subjects/Keywords: Cancer; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zamora, E. A. (2012). Dual labeling of syngeneic tumor cells for in vivo and in vitro localization. (Masters Thesis). University of Minnesota. Retrieved from http://purl.umn.edu/140180

Chicago Manual of Style (16th Edition):

Zamora, Edward Anthony. “Dual labeling of syngeneic tumor cells for in vivo and in vitro localization.” 2012. Masters Thesis, University of Minnesota. Accessed September 26, 2020. http://purl.umn.edu/140180.

MLA Handbook (7th Edition):

Zamora, Edward Anthony. “Dual labeling of syngeneic tumor cells for in vivo and in vitro localization.” 2012. Web. 26 Sep 2020.

Vancouver:

Zamora EA. Dual labeling of syngeneic tumor cells for in vivo and in vitro localization. [Internet] [Masters thesis]. University of Minnesota; 2012. [cited 2020 Sep 26]. Available from: http://purl.umn.edu/140180.

Council of Science Editors:

Zamora EA. Dual labeling of syngeneic tumor cells for in vivo and in vitro localization. [Masters Thesis]. University of Minnesota; 2012. Available from: http://purl.umn.edu/140180


University of Minnesota

2. Zamora, Edward Anthony. Dual labeling of syngeneic tumor cells for in vivo and in vitro localization.

Degree: MS, Microbiology, immunology and cancer biology, 2012, University of Minnesota

 Animal models in cancer research have been critical to much of our understanding of tumor biology. However, while early models have advanced the field, improvements… (more)

Subjects/Keywords: Cancer; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zamora, E. A. (2012). Dual labeling of syngeneic tumor cells for in vivo and in vitro localization. (Masters Thesis). University of Minnesota. Retrieved from http://purl.umn.edu/140180

Chicago Manual of Style (16th Edition):

Zamora, Edward Anthony. “Dual labeling of syngeneic tumor cells for in vivo and in vitro localization.” 2012. Masters Thesis, University of Minnesota. Accessed September 26, 2020. http://purl.umn.edu/140180.

MLA Handbook (7th Edition):

Zamora, Edward Anthony. “Dual labeling of syngeneic tumor cells for in vivo and in vitro localization.” 2012. Web. 26 Sep 2020.

Vancouver:

Zamora EA. Dual labeling of syngeneic tumor cells for in vivo and in vitro localization. [Internet] [Masters thesis]. University of Minnesota; 2012. [cited 2020 Sep 26]. Available from: http://purl.umn.edu/140180.

Council of Science Editors:

Zamora EA. Dual labeling of syngeneic tumor cells for in vivo and in vitro localization. [Masters Thesis]. University of Minnesota; 2012. Available from: http://purl.umn.edu/140180


Boston University

3. Kahn, Matthew Adam. Characterizing glucocorticoid receptor in metastatic castration resistant prostate cancer.

Degree: MS, Medical Sciences, 2020, Boston University

 The purpose of this paper is to characterize the glucocorticoid receptor (GR) signaling and relevance in the context of enzalutamide resistant prostate cancer cells. Enzalutamide… (more)

Subjects/Keywords: Oncology; Cancer; Prostate

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kahn, M. A. (2020). Characterizing glucocorticoid receptor in metastatic castration resistant prostate cancer. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/41278

Chicago Manual of Style (16th Edition):

Kahn, Matthew Adam. “Characterizing glucocorticoid receptor in metastatic castration resistant prostate cancer.” 2020. Masters Thesis, Boston University. Accessed September 26, 2020. http://hdl.handle.net/2144/41278.

MLA Handbook (7th Edition):

Kahn, Matthew Adam. “Characterizing glucocorticoid receptor in metastatic castration resistant prostate cancer.” 2020. Web. 26 Sep 2020.

Vancouver:

Kahn MA. Characterizing glucocorticoid receptor in metastatic castration resistant prostate cancer. [Internet] [Masters thesis]. Boston University; 2020. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/2144/41278.

Council of Science Editors:

Kahn MA. Characterizing glucocorticoid receptor in metastatic castration resistant prostate cancer. [Masters Thesis]. Boston University; 2020. Available from: http://hdl.handle.net/2144/41278


University of Lund

4. Savari, Sayeh. The role of CysLT1R in animal models of colorectal cancer.

Degree: 2014, University of Lund

 Cysteinyl leukotrienes (LTC4, LTD4 and LTE4) are potent pro-inflammatory lipids derived from arachidonic acid and mediate their effect through CysLT1R and CysLT2R. There is a… (more)

Subjects/Keywords: Cancer and Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Savari, S. (2014). The role of CysLT1R in animal models of colorectal cancer. (Doctoral Dissertation). University of Lund. Retrieved from https://lup.lub.lu.se/record/4447032 ; https://portal.research.lu.se/ws/files/3030418/4447038.pdf

Chicago Manual of Style (16th Edition):

Savari, Sayeh. “The role of CysLT1R in animal models of colorectal cancer.” 2014. Doctoral Dissertation, University of Lund. Accessed September 26, 2020. https://lup.lub.lu.se/record/4447032 ; https://portal.research.lu.se/ws/files/3030418/4447038.pdf.

MLA Handbook (7th Edition):

Savari, Sayeh. “The role of CysLT1R in animal models of colorectal cancer.” 2014. Web. 26 Sep 2020.

Vancouver:

Savari S. The role of CysLT1R in animal models of colorectal cancer. [Internet] [Doctoral dissertation]. University of Lund; 2014. [cited 2020 Sep 26]. Available from: https://lup.lub.lu.se/record/4447032 ; https://portal.research.lu.se/ws/files/3030418/4447038.pdf.

Council of Science Editors:

Savari S. The role of CysLT1R in animal models of colorectal cancer. [Doctoral Dissertation]. University of Lund; 2014. Available from: https://lup.lub.lu.se/record/4447032 ; https://portal.research.lu.se/ws/files/3030418/4447038.pdf


University of Lund

5. Isaksson, Sofi. Blood- and tumor-based analyses for improved prognostics in lung cancer.

Degree: 2019, University of Lund

 Lung cancer is a common cancer type associated with poor prognosis. Even in the group of patients with earlystage tumors, for which curative treatment is… (more)

Subjects/Keywords: Cancer and Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Isaksson, S. (2019). Blood- and tumor-based analyses for improved prognostics in lung cancer. (Doctoral Dissertation). University of Lund. Retrieved from https://lup.lub.lu.se/record/08b76218-a78f-4a03-be08-27683c40263c ; https://portal.research.lu.se/ws/files/63589824/Sofi_Isaksson_web.pdf

Chicago Manual of Style (16th Edition):

Isaksson, Sofi. “Blood- and tumor-based analyses for improved prognostics in lung cancer.” 2019. Doctoral Dissertation, University of Lund. Accessed September 26, 2020. https://lup.lub.lu.se/record/08b76218-a78f-4a03-be08-27683c40263c ; https://portal.research.lu.se/ws/files/63589824/Sofi_Isaksson_web.pdf.

MLA Handbook (7th Edition):

Isaksson, Sofi. “Blood- and tumor-based analyses for improved prognostics in lung cancer.” 2019. Web. 26 Sep 2020.

Vancouver:

Isaksson S. Blood- and tumor-based analyses for improved prognostics in lung cancer. [Internet] [Doctoral dissertation]. University of Lund; 2019. [cited 2020 Sep 26]. Available from: https://lup.lub.lu.se/record/08b76218-a78f-4a03-be08-27683c40263c ; https://portal.research.lu.se/ws/files/63589824/Sofi_Isaksson_web.pdf.

Council of Science Editors:

Isaksson S. Blood- and tumor-based analyses for improved prognostics in lung cancer. [Doctoral Dissertation]. University of Lund; 2019. Available from: https://lup.lub.lu.se/record/08b76218-a78f-4a03-be08-27683c40263c ; https://portal.research.lu.se/ws/files/63589824/Sofi_Isaksson_web.pdf


Queen Mary, University of London

6. Mercer, Emma. TMPRSS2 promoter driven enzyme-prodrug therapy for the treatment of PCa.

Degree: PhD, 2015, Queen Mary, University of London

 Prostate cancer (PCa) progression is dependent on transcriptional activation of the androgen receptor (AR) in the majority of cases. Therefore, therapies include anti-androgens, which decrease… (more)

Subjects/Keywords: Molecular Oncology; Cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mercer, E. (2015). TMPRSS2 promoter driven enzyme-prodrug therapy for the treatment of PCa. (Doctoral Dissertation). Queen Mary, University of London. Retrieved from http://qmro.qmul.ac.uk/xmlui/handle/123456789/11667 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.775121

Chicago Manual of Style (16th Edition):

Mercer, Emma. “TMPRSS2 promoter driven enzyme-prodrug therapy for the treatment of PCa.” 2015. Doctoral Dissertation, Queen Mary, University of London. Accessed September 26, 2020. http://qmro.qmul.ac.uk/xmlui/handle/123456789/11667 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.775121.

MLA Handbook (7th Edition):

Mercer, Emma. “TMPRSS2 promoter driven enzyme-prodrug therapy for the treatment of PCa.” 2015. Web. 26 Sep 2020.

Vancouver:

Mercer E. TMPRSS2 promoter driven enzyme-prodrug therapy for the treatment of PCa. [Internet] [Doctoral dissertation]. Queen Mary, University of London; 2015. [cited 2020 Sep 26]. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/11667 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.775121.

Council of Science Editors:

Mercer E. TMPRSS2 promoter driven enzyme-prodrug therapy for the treatment of PCa. [Doctoral Dissertation]. Queen Mary, University of London; 2015. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/11667 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.775121


University of Lund

7. Eleftheriou, Nikolas. TGF-β Family Signaling in Tumor Angiogenesis.

Degree: 2017, University of Lund

 Angiogenesis provides growing tumors a source of nutrients and oxygen, and a route for metastatic dissemination. In recent years anti-angiogenic therapies that primarily target the… (more)

Subjects/Keywords: Cancer and Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Eleftheriou, N. (2017). TGF-β Family Signaling in Tumor Angiogenesis. (Doctoral Dissertation). University of Lund. Retrieved from https://lup.lub.lu.se/record/95fd8af3-a666-4f1a-8c24-b5fb7ed35376 ; https://portal.research.lu.se/ws/files/21970145/Nikolas_Eleftheriou_komplett.pdf

Chicago Manual of Style (16th Edition):

Eleftheriou, Nikolas. “TGF-β Family Signaling in Tumor Angiogenesis.” 2017. Doctoral Dissertation, University of Lund. Accessed September 26, 2020. https://lup.lub.lu.se/record/95fd8af3-a666-4f1a-8c24-b5fb7ed35376 ; https://portal.research.lu.se/ws/files/21970145/Nikolas_Eleftheriou_komplett.pdf.

MLA Handbook (7th Edition):

Eleftheriou, Nikolas. “TGF-β Family Signaling in Tumor Angiogenesis.” 2017. Web. 26 Sep 2020.

Vancouver:

Eleftheriou N. TGF-β Family Signaling in Tumor Angiogenesis. [Internet] [Doctoral dissertation]. University of Lund; 2017. [cited 2020 Sep 26]. Available from: https://lup.lub.lu.se/record/95fd8af3-a666-4f1a-8c24-b5fb7ed35376 ; https://portal.research.lu.se/ws/files/21970145/Nikolas_Eleftheriou_komplett.pdf.

Council of Science Editors:

Eleftheriou N. TGF-β Family Signaling in Tumor Angiogenesis. [Doctoral Dissertation]. University of Lund; 2017. Available from: https://lup.lub.lu.se/record/95fd8af3-a666-4f1a-8c24-b5fb7ed35376 ; https://portal.research.lu.se/ws/files/21970145/Nikolas_Eleftheriou_komplett.pdf


University of Lund

8. Zarrizi, Reihaneh. Tumor Suppressor function of the deubiquitinating enzyme BAP1 and its substrate gamma-tubulin In regulation of cell cycle and genome stability.

Degree: 2015, University of Lund

 In normal cells, the cell cycle is controlled by a complex series of signalling pathways by which a cell grows, replicates its DNA and divides.… (more)

Subjects/Keywords: Cancer and Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zarrizi, R. (2015). Tumor Suppressor function of the deubiquitinating enzyme BAP1 and its substrate gamma-tubulin In regulation of cell cycle and genome stability. (Doctoral Dissertation). University of Lund. Retrieved from https://lup.lub.lu.se/record/5364894 ; https://portal.research.lu.se/ws/files/3256763/5365067.pdf

Chicago Manual of Style (16th Edition):

Zarrizi, Reihaneh. “Tumor Suppressor function of the deubiquitinating enzyme BAP1 and its substrate gamma-tubulin In regulation of cell cycle and genome stability.” 2015. Doctoral Dissertation, University of Lund. Accessed September 26, 2020. https://lup.lub.lu.se/record/5364894 ; https://portal.research.lu.se/ws/files/3256763/5365067.pdf.

MLA Handbook (7th Edition):

Zarrizi, Reihaneh. “Tumor Suppressor function of the deubiquitinating enzyme BAP1 and its substrate gamma-tubulin In regulation of cell cycle and genome stability.” 2015. Web. 26 Sep 2020.

Vancouver:

Zarrizi R. Tumor Suppressor function of the deubiquitinating enzyme BAP1 and its substrate gamma-tubulin In regulation of cell cycle and genome stability. [Internet] [Doctoral dissertation]. University of Lund; 2015. [cited 2020 Sep 26]. Available from: https://lup.lub.lu.se/record/5364894 ; https://portal.research.lu.se/ws/files/3256763/5365067.pdf.

Council of Science Editors:

Zarrizi R. Tumor Suppressor function of the deubiquitinating enzyme BAP1 and its substrate gamma-tubulin In regulation of cell cycle and genome stability. [Doctoral Dissertation]. University of Lund; 2015. Available from: https://lup.lub.lu.se/record/5364894 ; https://portal.research.lu.se/ws/files/3256763/5365067.pdf


University of Lund

9. Fjordén, Karin. Prognostic Markers and Mechanisms of Chemotherapy Resistance in Diffuse Large B-cell Lymphoma.

Degree: 2015, University of Lund

 Diffuse large B-cell lymphoma (DLBCL) is an aggressive and heterogeneous disease. Identification of prognostic and predictive markers is important to design individualised and effective treatment… (more)

Subjects/Keywords: Cancer and Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fjordén, K. (2015). Prognostic Markers and Mechanisms of Chemotherapy Resistance in Diffuse Large B-cell Lymphoma. (Doctoral Dissertation). University of Lund. Retrieved from https://lup.lub.lu.se/record/5051427 ; https://portal.research.lu.se/ws/files/3582954/5051430.pdf

Chicago Manual of Style (16th Edition):

Fjordén, Karin. “Prognostic Markers and Mechanisms of Chemotherapy Resistance in Diffuse Large B-cell Lymphoma.” 2015. Doctoral Dissertation, University of Lund. Accessed September 26, 2020. https://lup.lub.lu.se/record/5051427 ; https://portal.research.lu.se/ws/files/3582954/5051430.pdf.

MLA Handbook (7th Edition):

Fjordén, Karin. “Prognostic Markers and Mechanisms of Chemotherapy Resistance in Diffuse Large B-cell Lymphoma.” 2015. Web. 26 Sep 2020.

Vancouver:

Fjordén K. Prognostic Markers and Mechanisms of Chemotherapy Resistance in Diffuse Large B-cell Lymphoma. [Internet] [Doctoral dissertation]. University of Lund; 2015. [cited 2020 Sep 26]. Available from: https://lup.lub.lu.se/record/5051427 ; https://portal.research.lu.se/ws/files/3582954/5051430.pdf.

Council of Science Editors:

Fjordén K. Prognostic Markers and Mechanisms of Chemotherapy Resistance in Diffuse Large B-cell Lymphoma. [Doctoral Dissertation]. University of Lund; 2015. Available from: https://lup.lub.lu.se/record/5051427 ; https://portal.research.lu.se/ws/files/3582954/5051430.pdf


University of Central Florida

10. Higgins, Lyn. The Identification and Segmentation of Astrocytoma Prior to Critical Mass, by means of a Volumetric/Subregion Regression Analysis of Normal and Neoplastic Brain Tissue.

Degree: 2018, University of Central Florida

 As the underlying cause of Glioblastoma Multiforme (GBM) is presently unclear, this research implements a new approach to identifying and segmenting plausible instances of GBM… (more)

Subjects/Keywords: Cancer Biology; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Higgins, L. (2018). The Identification and Segmentation of Astrocytoma Prior to Critical Mass, by means of a Volumetric/Subregion Regression Analysis of Normal and Neoplastic Brain Tissue. (Masters Thesis). University of Central Florida. Retrieved from https://stars.library.ucf.edu/etd/6254

Chicago Manual of Style (16th Edition):

Higgins, Lyn. “The Identification and Segmentation of Astrocytoma Prior to Critical Mass, by means of a Volumetric/Subregion Regression Analysis of Normal and Neoplastic Brain Tissue.” 2018. Masters Thesis, University of Central Florida. Accessed September 26, 2020. https://stars.library.ucf.edu/etd/6254.

MLA Handbook (7th Edition):

Higgins, Lyn. “The Identification and Segmentation of Astrocytoma Prior to Critical Mass, by means of a Volumetric/Subregion Regression Analysis of Normal and Neoplastic Brain Tissue.” 2018. Web. 26 Sep 2020.

Vancouver:

Higgins L. The Identification and Segmentation of Astrocytoma Prior to Critical Mass, by means of a Volumetric/Subregion Regression Analysis of Normal and Neoplastic Brain Tissue. [Internet] [Masters thesis]. University of Central Florida; 2018. [cited 2020 Sep 26]. Available from: https://stars.library.ucf.edu/etd/6254.

Council of Science Editors:

Higgins L. The Identification and Segmentation of Astrocytoma Prior to Critical Mass, by means of a Volumetric/Subregion Regression Analysis of Normal and Neoplastic Brain Tissue. [Masters Thesis]. University of Central Florida; 2018. Available from: https://stars.library.ucf.edu/etd/6254

11. Elango, J Kalavathy. Risk profile of oral cancers and strategies to improve awareness and early detection.

Degree: 2009, Amrita Vishwa Vidyapeetham (University)

Fundamentals of implementing any cancer control programs are the understanding of the burden of the disease in the community (incidence trends), risk factor profile and… (more)

Subjects/Keywords: Oral cancer; Oncology; Cancer prevention; Cancer treatment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Elango, J. K. (2009). Risk profile of oral cancers and strategies to improve awareness and early detection. (Thesis). Amrita Vishwa Vidyapeetham (University). Retrieved from http://shodhganga.inflibnet.ac.in/handle/10603/2363

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Elango, J Kalavathy. “Risk profile of oral cancers and strategies to improve awareness and early detection.” 2009. Thesis, Amrita Vishwa Vidyapeetham (University). Accessed September 26, 2020. http://shodhganga.inflibnet.ac.in/handle/10603/2363.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Elango, J Kalavathy. “Risk profile of oral cancers and strategies to improve awareness and early detection.” 2009. Web. 26 Sep 2020.

Vancouver:

Elango JK. Risk profile of oral cancers and strategies to improve awareness and early detection. [Internet] [Thesis]. Amrita Vishwa Vidyapeetham (University); 2009. [cited 2020 Sep 26]. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/2363.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Elango JK. Risk profile of oral cancers and strategies to improve awareness and early detection. [Thesis]. Amrita Vishwa Vidyapeetham (University); 2009. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/2363

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Newcastle

12. Copeland, Ben Troy. Tetraspanins as biomarkers and causative proteins in prostate cancer.

Degree: PhD, 2013, University of Newcastle

Research Doctorate - Doctor of Philosophy (PhD)

Prostate cancer (PCa) is the most commonly diagnosed solid cancer and the cause of the second highest mortality… (more)

Subjects/Keywords: oncology; prostate cancer; tetraspanin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Copeland, B. T. (2013). Tetraspanins as biomarkers and causative proteins in prostate cancer. (Doctoral Dissertation). University of Newcastle. Retrieved from http://hdl.handle.net/1959.13/1039255

Chicago Manual of Style (16th Edition):

Copeland, Ben Troy. “Tetraspanins as biomarkers and causative proteins in prostate cancer.” 2013. Doctoral Dissertation, University of Newcastle. Accessed September 26, 2020. http://hdl.handle.net/1959.13/1039255.

MLA Handbook (7th Edition):

Copeland, Ben Troy. “Tetraspanins as biomarkers and causative proteins in prostate cancer.” 2013. Web. 26 Sep 2020.

Vancouver:

Copeland BT. Tetraspanins as biomarkers and causative proteins in prostate cancer. [Internet] [Doctoral dissertation]. University of Newcastle; 2013. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/1959.13/1039255.

Council of Science Editors:

Copeland BT. Tetraspanins as biomarkers and causative proteins in prostate cancer. [Doctoral Dissertation]. University of Newcastle; 2013. Available from: http://hdl.handle.net/1959.13/1039255


Columbia University

13. Henckels, Eric Patrick. Regulation of Matrix Metallopeptidase-1 in Breast Cancer Metastasis.

Degree: 2013, Columbia University

 Matrix Metallopeptidase 1 (MMP-1) expression has repeatedly been correlated to tumorigenesis and metastasis. Yet, MMP-1 regulation in a metastatic context remains largely unknown. Here we… (more)

Subjects/Keywords: Oncology; Metastasis; Carcinogenesis; Breast – Cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Henckels, E. P. (2013). Regulation of Matrix Metallopeptidase-1 in Breast Cancer Metastasis. (Doctoral Dissertation). Columbia University. Retrieved from https://doi.org/10.7916/D8TT4Z9W

Chicago Manual of Style (16th Edition):

Henckels, Eric Patrick. “Regulation of Matrix Metallopeptidase-1 in Breast Cancer Metastasis.” 2013. Doctoral Dissertation, Columbia University. Accessed September 26, 2020. https://doi.org/10.7916/D8TT4Z9W.

MLA Handbook (7th Edition):

Henckels, Eric Patrick. “Regulation of Matrix Metallopeptidase-1 in Breast Cancer Metastasis.” 2013. Web. 26 Sep 2020.

Vancouver:

Henckels EP. Regulation of Matrix Metallopeptidase-1 in Breast Cancer Metastasis. [Internet] [Doctoral dissertation]. Columbia University; 2013. [cited 2020 Sep 26]. Available from: https://doi.org/10.7916/D8TT4Z9W.

Council of Science Editors:

Henckels EP. Regulation of Matrix Metallopeptidase-1 in Breast Cancer Metastasis. [Doctoral Dissertation]. Columbia University; 2013. Available from: https://doi.org/10.7916/D8TT4Z9W


Queen Mary, University of London

14. Young, Anna-Mary. Development of an immunocompetent model of oncolytic adenoviral gene therapy for ovarian cancer.

Degree: PhD, 2012, Queen Mary, University of London

 Oncolytic adenoviral gene therapy has potential as a novel anti-cancer agent for ovarian cancer. Host immune responses are thought to contribute to its therapeutic effects.… (more)

Subjects/Keywords: 616.99; Medicine; Oncology; Ovarian cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Young, A. (2012). Development of an immunocompetent model of oncolytic adenoviral gene therapy for ovarian cancer. (Doctoral Dissertation). Queen Mary, University of London. Retrieved from http://qmro.qmul.ac.uk/xmlui/handle/123456789/8365 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.664879

Chicago Manual of Style (16th Edition):

Young, Anna-Mary. “Development of an immunocompetent model of oncolytic adenoviral gene therapy for ovarian cancer.” 2012. Doctoral Dissertation, Queen Mary, University of London. Accessed September 26, 2020. http://qmro.qmul.ac.uk/xmlui/handle/123456789/8365 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.664879.

MLA Handbook (7th Edition):

Young, Anna-Mary. “Development of an immunocompetent model of oncolytic adenoviral gene therapy for ovarian cancer.” 2012. Web. 26 Sep 2020.

Vancouver:

Young A. Development of an immunocompetent model of oncolytic adenoviral gene therapy for ovarian cancer. [Internet] [Doctoral dissertation]. Queen Mary, University of London; 2012. [cited 2020 Sep 26]. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/8365 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.664879.

Council of Science Editors:

Young A. Development of an immunocompetent model of oncolytic adenoviral gene therapy for ovarian cancer. [Doctoral Dissertation]. Queen Mary, University of London; 2012. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/8365 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.664879


Queen Mary, University of London

15. Boshoff, Ana Sousa Marcelino. Targeting thyroid stimulating hormone receptors in radioiodine resistant dedifferentiated thyroid cancer.

Degree: PhD, 2012, Queen Mary, University of London

 The most common type of thyroid cancer, differentiated thyroid cancer (DTC), is diagnosed by radioactive iodine whole body scanning (WBS) and treated with radiotherapy using… (more)

Subjects/Keywords: 616.99; Medicine; Thyroid cancer; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Boshoff, A. S. M. (2012). Targeting thyroid stimulating hormone receptors in radioiodine resistant dedifferentiated thyroid cancer. (Doctoral Dissertation). Queen Mary, University of London. Retrieved from http://qmro.qmul.ac.uk/xmlui/handle/123456789/8311 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.664915

Chicago Manual of Style (16th Edition):

Boshoff, Ana Sousa Marcelino. “Targeting thyroid stimulating hormone receptors in radioiodine resistant dedifferentiated thyroid cancer.” 2012. Doctoral Dissertation, Queen Mary, University of London. Accessed September 26, 2020. http://qmro.qmul.ac.uk/xmlui/handle/123456789/8311 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.664915.

MLA Handbook (7th Edition):

Boshoff, Ana Sousa Marcelino. “Targeting thyroid stimulating hormone receptors in radioiodine resistant dedifferentiated thyroid cancer.” 2012. Web. 26 Sep 2020.

Vancouver:

Boshoff ASM. Targeting thyroid stimulating hormone receptors in radioiodine resistant dedifferentiated thyroid cancer. [Internet] [Doctoral dissertation]. Queen Mary, University of London; 2012. [cited 2020 Sep 26]. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/8311 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.664915.

Council of Science Editors:

Boshoff ASM. Targeting thyroid stimulating hormone receptors in radioiodine resistant dedifferentiated thyroid cancer. [Doctoral Dissertation]. Queen Mary, University of London; 2012. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/8311 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.664915


University of Sydney

16. Sarich, Peter. Alcohol Consumption and Cancer Incidence and Mortality in Australia: A Prospective Cohort Analysis of the New South Wales 45 and Up Study.

Degree: 2018, University of Sydney

 In 2011, it was estimated that over 5% of the burden of disease and injury in Australia was attributable to alcohol consumption. There is a… (more)

Subjects/Keywords: alcohol; cancer; oncology; mortality; epidemiology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sarich, P. (2018). Alcohol Consumption and Cancer Incidence and Mortality in Australia: A Prospective Cohort Analysis of the New South Wales 45 and Up Study. (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/19615

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sarich, Peter. “Alcohol Consumption and Cancer Incidence and Mortality in Australia: A Prospective Cohort Analysis of the New South Wales 45 and Up Study. ” 2018. Thesis, University of Sydney. Accessed September 26, 2020. http://hdl.handle.net/2123/19615.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sarich, Peter. “Alcohol Consumption and Cancer Incidence and Mortality in Australia: A Prospective Cohort Analysis of the New South Wales 45 and Up Study. ” 2018. Web. 26 Sep 2020.

Vancouver:

Sarich P. Alcohol Consumption and Cancer Incidence and Mortality in Australia: A Prospective Cohort Analysis of the New South Wales 45 and Up Study. [Internet] [Thesis]. University of Sydney; 2018. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/2123/19615.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sarich P. Alcohol Consumption and Cancer Incidence and Mortality in Australia: A Prospective Cohort Analysis of the New South Wales 45 and Up Study. [Thesis]. University of Sydney; 2018. Available from: http://hdl.handle.net/2123/19615

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Rutgers University

17. Kotfila, Joshua M. Understanding the use and disclosure of natural products by cancer patients.

Degree: PhD, Health Sciences, 2016, Rutgers University

Background: Although cancer patients frequently use natural products (NP) to complement conventional oncology treatments and often do not disclose NP use to their healthcare providers,… (more)

Subjects/Keywords: Oncology; Cancer – Alternative treatment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kotfila, J. M. (2016). Understanding the use and disclosure of natural products by cancer patients. (Doctoral Dissertation). Rutgers University. Retrieved from https://rucore.libraries.rutgers.edu/rutgers-lib/49740/

Chicago Manual of Style (16th Edition):

Kotfila, Joshua M. “Understanding the use and disclosure of natural products by cancer patients.” 2016. Doctoral Dissertation, Rutgers University. Accessed September 26, 2020. https://rucore.libraries.rutgers.edu/rutgers-lib/49740/.

MLA Handbook (7th Edition):

Kotfila, Joshua M. “Understanding the use and disclosure of natural products by cancer patients.” 2016. Web. 26 Sep 2020.

Vancouver:

Kotfila JM. Understanding the use and disclosure of natural products by cancer patients. [Internet] [Doctoral dissertation]. Rutgers University; 2016. [cited 2020 Sep 26]. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/49740/.

Council of Science Editors:

Kotfila JM. Understanding the use and disclosure of natural products by cancer patients. [Doctoral Dissertation]. Rutgers University; 2016. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/49740/


University of Toronto

18. Thevakumaran, Neroshan. Structural and Functional Characterization of RAF Allosteric Regulation.

Degree: PhD, 2017, University of Toronto

 The RAS-ERK/MAPK pathway is a critical signalling pathway regulating cell growth, proliferation, and survival. As such, aberrant signalling through this pathway is often associated with… (more)

Subjects/Keywords: cancer; kinase; oncology; RAF; 0487

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Thevakumaran, N. (2017). Structural and Functional Characterization of RAF Allosteric Regulation. (Doctoral Dissertation). University of Toronto. Retrieved from http://hdl.handle.net/1807/80885

Chicago Manual of Style (16th Edition):

Thevakumaran, Neroshan. “Structural and Functional Characterization of RAF Allosteric Regulation.” 2017. Doctoral Dissertation, University of Toronto. Accessed September 26, 2020. http://hdl.handle.net/1807/80885.

MLA Handbook (7th Edition):

Thevakumaran, Neroshan. “Structural and Functional Characterization of RAF Allosteric Regulation.” 2017. Web. 26 Sep 2020.

Vancouver:

Thevakumaran N. Structural and Functional Characterization of RAF Allosteric Regulation. [Internet] [Doctoral dissertation]. University of Toronto; 2017. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/1807/80885.

Council of Science Editors:

Thevakumaran N. Structural and Functional Characterization of RAF Allosteric Regulation. [Doctoral Dissertation]. University of Toronto; 2017. Available from: http://hdl.handle.net/1807/80885


University of Lund

19. Jansson, Sara. Receptor tyrosine kinases and circulating tumor cells as new prognostic biomarkers in breast cancer with special focus on TNBC.

Degree: 2017, University of Lund

 About 8000 Swedish women are diagnosed with breast cancer each year, and around 1500 die from the disease. Triple-negative breast cancer (TNBC) constitutes 7-14% of… (more)

Subjects/Keywords: Cancer and Oncology; bröstcancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jansson, S. (2017). Receptor tyrosine kinases and circulating tumor cells as new prognostic biomarkers in breast cancer with special focus on TNBC. (Doctoral Dissertation). University of Lund. Retrieved from https://lup.lub.lu.se/record/bc9d1b89-8126-44d1-ab6e-296450a3c5a8 ; https://portal.research.lu.se/ws/files/35175110/Sara_Jansson_avh_G5_nr2_kappan.pdf

Chicago Manual of Style (16th Edition):

Jansson, Sara. “Receptor tyrosine kinases and circulating tumor cells as new prognostic biomarkers in breast cancer with special focus on TNBC.” 2017. Doctoral Dissertation, University of Lund. Accessed September 26, 2020. https://lup.lub.lu.se/record/bc9d1b89-8126-44d1-ab6e-296450a3c5a8 ; https://portal.research.lu.se/ws/files/35175110/Sara_Jansson_avh_G5_nr2_kappan.pdf.

MLA Handbook (7th Edition):

Jansson, Sara. “Receptor tyrosine kinases and circulating tumor cells as new prognostic biomarkers in breast cancer with special focus on TNBC.” 2017. Web. 26 Sep 2020.

Vancouver:

Jansson S. Receptor tyrosine kinases and circulating tumor cells as new prognostic biomarkers in breast cancer with special focus on TNBC. [Internet] [Doctoral dissertation]. University of Lund; 2017. [cited 2020 Sep 26]. Available from: https://lup.lub.lu.se/record/bc9d1b89-8126-44d1-ab6e-296450a3c5a8 ; https://portal.research.lu.se/ws/files/35175110/Sara_Jansson_avh_G5_nr2_kappan.pdf.

Council of Science Editors:

Jansson S. Receptor tyrosine kinases and circulating tumor cells as new prognostic biomarkers in breast cancer with special focus on TNBC. [Doctoral Dissertation]. University of Lund; 2017. Available from: https://lup.lub.lu.se/record/bc9d1b89-8126-44d1-ab6e-296450a3c5a8 ; https://portal.research.lu.se/ws/files/35175110/Sara_Jansson_avh_G5_nr2_kappan.pdf


Virginia Tech

20. Brock, Rebecca Michaela. The Biological and Immunological Effects of Irreversible Electroporation and Combination Therapy Options for the Improving the Treatment of Pancreatic Cancer.

Degree: PhD, Translational Biology, Medicine and Health, 2020, Virginia Tech

 While cancer treatments have advanced for multiple cancers, pancreatic cancer remains a lethal cancer with few therapy options available. This is due to limited surgical… (more)

Subjects/Keywords: oncology; immunology; biomedical; cancer; inflammation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Brock, R. M. (2020). The Biological and Immunological Effects of Irreversible Electroporation and Combination Therapy Options for the Improving the Treatment of Pancreatic Cancer. (Doctoral Dissertation). Virginia Tech. Retrieved from http://hdl.handle.net/10919/98775

Chicago Manual of Style (16th Edition):

Brock, Rebecca Michaela. “The Biological and Immunological Effects of Irreversible Electroporation and Combination Therapy Options for the Improving the Treatment of Pancreatic Cancer.” 2020. Doctoral Dissertation, Virginia Tech. Accessed September 26, 2020. http://hdl.handle.net/10919/98775.

MLA Handbook (7th Edition):

Brock, Rebecca Michaela. “The Biological and Immunological Effects of Irreversible Electroporation and Combination Therapy Options for the Improving the Treatment of Pancreatic Cancer.” 2020. Web. 26 Sep 2020.

Vancouver:

Brock RM. The Biological and Immunological Effects of Irreversible Electroporation and Combination Therapy Options for the Improving the Treatment of Pancreatic Cancer. [Internet] [Doctoral dissertation]. Virginia Tech; 2020. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/10919/98775.

Council of Science Editors:

Brock RM. The Biological and Immunological Effects of Irreversible Electroporation and Combination Therapy Options for the Improving the Treatment of Pancreatic Cancer. [Doctoral Dissertation]. Virginia Tech; 2020. Available from: http://hdl.handle.net/10919/98775


Boston University

21. Lee, Tian Yu. The role and function of SOX11 in DNA damage in triple-negative breast cancer.

Degree: MS, Medical Sciences, 2019, Boston University

 Breast cancer is a complex heterogenous disease that consists of several different subtypes displaying distinct behaviors and responses to different treatments. It is the second… (more)

Subjects/Keywords: Oncology; Breast cancer; Triple-negative breast cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lee, T. Y. (2019). The role and function of SOX11 in DNA damage in triple-negative breast cancer. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/36570

Chicago Manual of Style (16th Edition):

Lee, Tian Yu. “The role and function of SOX11 in DNA damage in triple-negative breast cancer.” 2019. Masters Thesis, Boston University. Accessed September 26, 2020. http://hdl.handle.net/2144/36570.

MLA Handbook (7th Edition):

Lee, Tian Yu. “The role and function of SOX11 in DNA damage in triple-negative breast cancer.” 2019. Web. 26 Sep 2020.

Vancouver:

Lee TY. The role and function of SOX11 in DNA damage in triple-negative breast cancer. [Internet] [Masters thesis]. Boston University; 2019. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/2144/36570.

Council of Science Editors:

Lee TY. The role and function of SOX11 in DNA damage in triple-negative breast cancer. [Masters Thesis]. Boston University; 2019. Available from: http://hdl.handle.net/2144/36570


Temple University

22. Sambandam, Vaishnavi. The Role of Hedgehog signaling in Hepatitis B virus X protein mediated hepatocellular carcinoma.

Degree: PhD, 2014, Temple University

Biology

Hepatitis B virus encoded X protein (HBx) contributes centrally to the pathogenesis of hepatocellular carcinoma (HCC). Aberrant activation of the Hedgehog (Hh) pathway has… (more)

Subjects/Keywords: Oncology; Molecular biology; Biology;

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sambandam, V. (2014). The Role of Hedgehog signaling in Hepatitis B virus X protein mediated hepatocellular carcinoma. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,292349

Chicago Manual of Style (16th Edition):

Sambandam, Vaishnavi. “The Role of Hedgehog signaling in Hepatitis B virus X protein mediated hepatocellular carcinoma.” 2014. Doctoral Dissertation, Temple University. Accessed September 26, 2020. http://digital.library.temple.edu/u?/p245801coll10,292349.

MLA Handbook (7th Edition):

Sambandam, Vaishnavi. “The Role of Hedgehog signaling in Hepatitis B virus X protein mediated hepatocellular carcinoma.” 2014. Web. 26 Sep 2020.

Vancouver:

Sambandam V. The Role of Hedgehog signaling in Hepatitis B virus X protein mediated hepatocellular carcinoma. [Internet] [Doctoral dissertation]. Temple University; 2014. [cited 2020 Sep 26]. Available from: http://digital.library.temple.edu/u?/p245801coll10,292349.

Council of Science Editors:

Sambandam V. The Role of Hedgehog signaling in Hepatitis B virus X protein mediated hepatocellular carcinoma. [Doctoral Dissertation]. Temple University; 2014. Available from: http://digital.library.temple.edu/u?/p245801coll10,292349


McMaster University

23. Syed, Iqra A. KNOWLEDGE OF DIAGNOSIS, TREATMENT AND LATE EFFECTS IN ADOLESCENT AND YOUNG ADULT SURVIVORS OF CHILDHOOD AND ADOLESCENT CANCER.

Degree: MSc, 2013, McMaster University

Abstract Purpose: While most children diagnosed with cancer survive their initial disease, the intensive treatments they receive place them at risk for late effects.… (more)

Subjects/Keywords: cancer; neoplasm; knowledge; Adolescent and young adult; survivor; Oncology; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Syed, I. A. (2013). KNOWLEDGE OF DIAGNOSIS, TREATMENT AND LATE EFFECTS IN ADOLESCENT AND YOUNG ADULT SURVIVORS OF CHILDHOOD AND ADOLESCENT CANCER. (Masters Thesis). McMaster University. Retrieved from http://hdl.handle.net/11375/15296

Chicago Manual of Style (16th Edition):

Syed, Iqra A. “KNOWLEDGE OF DIAGNOSIS, TREATMENT AND LATE EFFECTS IN ADOLESCENT AND YOUNG ADULT SURVIVORS OF CHILDHOOD AND ADOLESCENT CANCER.” 2013. Masters Thesis, McMaster University. Accessed September 26, 2020. http://hdl.handle.net/11375/15296.

MLA Handbook (7th Edition):

Syed, Iqra A. “KNOWLEDGE OF DIAGNOSIS, TREATMENT AND LATE EFFECTS IN ADOLESCENT AND YOUNG ADULT SURVIVORS OF CHILDHOOD AND ADOLESCENT CANCER.” 2013. Web. 26 Sep 2020.

Vancouver:

Syed IA. KNOWLEDGE OF DIAGNOSIS, TREATMENT AND LATE EFFECTS IN ADOLESCENT AND YOUNG ADULT SURVIVORS OF CHILDHOOD AND ADOLESCENT CANCER. [Internet] [Masters thesis]. McMaster University; 2013. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/11375/15296.

Council of Science Editors:

Syed IA. KNOWLEDGE OF DIAGNOSIS, TREATMENT AND LATE EFFECTS IN ADOLESCENT AND YOUNG ADULT SURVIVORS OF CHILDHOOD AND ADOLESCENT CANCER. [Masters Thesis]. McMaster University; 2013. Available from: http://hdl.handle.net/11375/15296


Harvard University

24. McKeown, Michael Robert. Chemical Probes and the Exploration of Bromodomains in Cancer Biology.

Degree: PhD, Chemical Biology, 2014, Harvard University

 The post-translational modification of histones and their interaction with transcription factors is essential to gene regulation. Furthermore, these targets would greatly benefit from probe molecules… (more)

Subjects/Keywords: Biochemistry; Cellular biology; Oncology; Bromodomain; Cancer; DLBCL; Inhibitor; Lymphoma; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

McKeown, M. R. (2014). Chemical Probes and the Exploration of Bromodomains in Cancer Biology. (Doctoral Dissertation). Harvard University. Retrieved from http://nrs.harvard.edu/urn-3:HUL.InstRepos:12269851

Chicago Manual of Style (16th Edition):

McKeown, Michael Robert. “Chemical Probes and the Exploration of Bromodomains in Cancer Biology.” 2014. Doctoral Dissertation, Harvard University. Accessed September 26, 2020. http://nrs.harvard.edu/urn-3:HUL.InstRepos:12269851.

MLA Handbook (7th Edition):

McKeown, Michael Robert. “Chemical Probes and the Exploration of Bromodomains in Cancer Biology.” 2014. Web. 26 Sep 2020.

Vancouver:

McKeown MR. Chemical Probes and the Exploration of Bromodomains in Cancer Biology. [Internet] [Doctoral dissertation]. Harvard University; 2014. [cited 2020 Sep 26]. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:12269851.

Council of Science Editors:

McKeown MR. Chemical Probes and the Exploration of Bromodomains in Cancer Biology. [Doctoral Dissertation]. Harvard University; 2014. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:12269851


Washington State University

25. [No author]. PROVIDER WEIGHT BIAS: EXPEREINCES OF OVERWEIGHT AND OBESE CANCER SURVIVORS .

Degree: 2016, Washington State University

 Declared a disease by the AMA in 2013, obesity claims the lives of over 2.8 million people annually in the U.S. Mounting evidence indicates weight… (more)

Subjects/Keywords: Nursing; Oncology; Cancer Survivor; Nursing; Obesity; Oncology Providers; Weight Bias

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

author], [. (2016). PROVIDER WEIGHT BIAS: EXPEREINCES OF OVERWEIGHT AND OBESE CANCER SURVIVORS . (Thesis). Washington State University. Retrieved from http://hdl.handle.net/2376/12126

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

author], [No. “PROVIDER WEIGHT BIAS: EXPEREINCES OF OVERWEIGHT AND OBESE CANCER SURVIVORS .” 2016. Thesis, Washington State University. Accessed September 26, 2020. http://hdl.handle.net/2376/12126.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

author], [No. “PROVIDER WEIGHT BIAS: EXPEREINCES OF OVERWEIGHT AND OBESE CANCER SURVIVORS .” 2016. Web. 26 Sep 2020.

Vancouver:

author] [. PROVIDER WEIGHT BIAS: EXPEREINCES OF OVERWEIGHT AND OBESE CANCER SURVIVORS . [Internet] [Thesis]. Washington State University; 2016. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/2376/12126.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

author] [. PROVIDER WEIGHT BIAS: EXPEREINCES OF OVERWEIGHT AND OBESE CANCER SURVIVORS . [Thesis]. Washington State University; 2016. Available from: http://hdl.handle.net/2376/12126

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Virginia Commonwealth University

26. Fernández, Elena V. NEW PERSISTENT AND CHRONIC OPIOID USE IN CANCER SURVIVORS AFTER CURATIVE INTENT RADIATION.

Degree: PhD, Pharmaceutical Sciences, 2020, Virginia Commonwealth University

  Background: Emerging evidence suggests that as more patients are surviving cancer, new persistent opioid use (no prior exposure to opioids before cancer therapy but… (more)

Subjects/Keywords: Cancer Survivors; Opioid Use; Radiation Oncology; Oncology; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fernández, E. V. (2020). NEW PERSISTENT AND CHRONIC OPIOID USE IN CANCER SURVIVORS AFTER CURATIVE INTENT RADIATION. (Doctoral Dissertation). Virginia Commonwealth University. Retrieved from https://scholarscompass.vcu.edu/etd/6392

Chicago Manual of Style (16th Edition):

Fernández, Elena V. “NEW PERSISTENT AND CHRONIC OPIOID USE IN CANCER SURVIVORS AFTER CURATIVE INTENT RADIATION.” 2020. Doctoral Dissertation, Virginia Commonwealth University. Accessed September 26, 2020. https://scholarscompass.vcu.edu/etd/6392.

MLA Handbook (7th Edition):

Fernández, Elena V. “NEW PERSISTENT AND CHRONIC OPIOID USE IN CANCER SURVIVORS AFTER CURATIVE INTENT RADIATION.” 2020. Web. 26 Sep 2020.

Vancouver:

Fernández EV. NEW PERSISTENT AND CHRONIC OPIOID USE IN CANCER SURVIVORS AFTER CURATIVE INTENT RADIATION. [Internet] [Doctoral dissertation]. Virginia Commonwealth University; 2020. [cited 2020 Sep 26]. Available from: https://scholarscompass.vcu.edu/etd/6392.

Council of Science Editors:

Fernández EV. NEW PERSISTENT AND CHRONIC OPIOID USE IN CANCER SURVIVORS AFTER CURATIVE INTENT RADIATION. [Doctoral Dissertation]. Virginia Commonwealth University; 2020. Available from: https://scholarscompass.vcu.edu/etd/6392


University of Oxford

27. Scott, Jacob G. Mathematical modelling of tumour evolution and radiation response : the impact of heterogeneity.

Degree: PhD, 2016, University of Oxford

 This thesis seeks to use mathematical and computational models to develop measures of clinically available data to deepen our understanding, and improve our treatments, of… (more)

Subjects/Keywords: 616.99; Oncology; mathematical modeling; radiation therapy; mathematical oncology; cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Scott, J. G. (2016). Mathematical modelling of tumour evolution and radiation response : the impact of heterogeneity. (Doctoral Dissertation). University of Oxford. Retrieved from http://ora.ox.ac.uk/objects/uuid:a318d567-9f5c-4632-8fab-0ec3f4229a5e ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.748664

Chicago Manual of Style (16th Edition):

Scott, Jacob G. “Mathematical modelling of tumour evolution and radiation response : the impact of heterogeneity.” 2016. Doctoral Dissertation, University of Oxford. Accessed September 26, 2020. http://ora.ox.ac.uk/objects/uuid:a318d567-9f5c-4632-8fab-0ec3f4229a5e ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.748664.

MLA Handbook (7th Edition):

Scott, Jacob G. “Mathematical modelling of tumour evolution and radiation response : the impact of heterogeneity.” 2016. Web. 26 Sep 2020.

Vancouver:

Scott JG. Mathematical modelling of tumour evolution and radiation response : the impact of heterogeneity. [Internet] [Doctoral dissertation]. University of Oxford; 2016. [cited 2020 Sep 26]. Available from: http://ora.ox.ac.uk/objects/uuid:a318d567-9f5c-4632-8fab-0ec3f4229a5e ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.748664.

Council of Science Editors:

Scott JG. Mathematical modelling of tumour evolution and radiation response : the impact of heterogeneity. [Doctoral Dissertation]. University of Oxford; 2016. Available from: http://ora.ox.ac.uk/objects/uuid:a318d567-9f5c-4632-8fab-0ec3f4229a5e ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.748664


University of Cambridge

28. Al-Khalidi, Sarwah. Genomic aberrations as determinants of immune infiltrates in high grade serous ovarian carcinoma.

Degree: PhD, 2020, University of Cambridge

 Despite increasing reports indicating the prognostic significance of immune cell abundance in high grade serous ovarian cancer (HGSOC), mutational processes by which tumours gain immunogenicity… (more)

Subjects/Keywords: Cancer; Ovarian; immune; Immun-Oncology; Oncology; Genomic Aberration; Copy number alterations

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Al-Khalidi, S. (2020). Genomic aberrations as determinants of immune infiltrates in high grade serous ovarian carcinoma. (Doctoral Dissertation). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/303391

Chicago Manual of Style (16th Edition):

Al-Khalidi, Sarwah. “Genomic aberrations as determinants of immune infiltrates in high grade serous ovarian carcinoma.” 2020. Doctoral Dissertation, University of Cambridge. Accessed September 26, 2020. https://www.repository.cam.ac.uk/handle/1810/303391.

MLA Handbook (7th Edition):

Al-Khalidi, Sarwah. “Genomic aberrations as determinants of immune infiltrates in high grade serous ovarian carcinoma.” 2020. Web. 26 Sep 2020.

Vancouver:

Al-Khalidi S. Genomic aberrations as determinants of immune infiltrates in high grade serous ovarian carcinoma. [Internet] [Doctoral dissertation]. University of Cambridge; 2020. [cited 2020 Sep 26]. Available from: https://www.repository.cam.ac.uk/handle/1810/303391.

Council of Science Editors:

Al-Khalidi S. Genomic aberrations as determinants of immune infiltrates in high grade serous ovarian carcinoma. [Doctoral Dissertation]. University of Cambridge; 2020. Available from: https://www.repository.cam.ac.uk/handle/1810/303391


Brigham Young University

29. Collett, Joan M. Oncology Nurses' Impact Scores for Obstacles and Supportive Behaviors at the End of Life.

Degree: MS, 2011, Brigham Young University

  Introduction: Oncology nurses provide end-of-life (EOL) care to their patients daily. Oncology nurses' perceptions regarding how to provide quality care to dying patients could… (more)

Subjects/Keywords: End-of-Life; oncology; oncology nurses; death; cancer; Nursing

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Collett, J. M. (2011). Oncology Nurses' Impact Scores for Obstacles and Supportive Behaviors at the End of Life. (Masters Thesis). Brigham Young University. Retrieved from https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=3672&context=etd

Chicago Manual of Style (16th Edition):

Collett, Joan M. “Oncology Nurses' Impact Scores for Obstacles and Supportive Behaviors at the End of Life.” 2011. Masters Thesis, Brigham Young University. Accessed September 26, 2020. https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=3672&context=etd.

MLA Handbook (7th Edition):

Collett, Joan M. “Oncology Nurses' Impact Scores for Obstacles and Supportive Behaviors at the End of Life.” 2011. Web. 26 Sep 2020.

Vancouver:

Collett JM. Oncology Nurses' Impact Scores for Obstacles and Supportive Behaviors at the End of Life. [Internet] [Masters thesis]. Brigham Young University; 2011. [cited 2020 Sep 26]. Available from: https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=3672&context=etd.

Council of Science Editors:

Collett JM. Oncology Nurses' Impact Scores for Obstacles and Supportive Behaviors at the End of Life. [Masters Thesis]. Brigham Young University; 2011. Available from: https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=3672&context=etd


University of California – San Francisco

30. Chang, Matthew Tsn-Wei. Systematic identification of driver mutations in cancer.

Degree: Pharmaceutical Sciences and Pharmacogenomics, 2016, University of California – San Francisco

 The advent of next-generation sequencing has accelerated the search for somatic mutations that drive the initiation and progression of human cancers. Much emphasis has been… (more)

Subjects/Keywords: Bioinformatics; Oncology; Biology; Bioinformatics; Biology; Cancer genomics; Oncology; Translational research

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chang, M. T. (2016). Systematic identification of driver mutations in cancer. (Thesis). University of California – San Francisco. Retrieved from http://www.escholarship.org/uc/item/0s53q62g

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chang, Matthew Tsn-Wei. “Systematic identification of driver mutations in cancer.” 2016. Thesis, University of California – San Francisco. Accessed September 26, 2020. http://www.escholarship.org/uc/item/0s53q62g.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chang, Matthew Tsn-Wei. “Systematic identification of driver mutations in cancer.” 2016. Web. 26 Sep 2020.

Vancouver:

Chang MT. Systematic identification of driver mutations in cancer. [Internet] [Thesis]. University of California – San Francisco; 2016. [cited 2020 Sep 26]. Available from: http://www.escholarship.org/uc/item/0s53q62g.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chang MT. Systematic identification of driver mutations in cancer. [Thesis]. University of California – San Francisco; 2016. Available from: http://www.escholarship.org/uc/item/0s53q62g

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2] [3] [4] [5] … [86]

.